New drug CIT-013 gets first safety check in healthy people
NCT ID NCT07499908
First seen Mar 30, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This early-stage trial tests the safety and tolerability of a new drug, CIT-013, in 10 healthy adults. Participants receive either the drug or a placebo to see how the body handles it. The study aims to gather initial safety data before testing in patients with a disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ICON
Groningen, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.